LSP1 rs3817198: Understanding This Breast Cancer Risk Variant
The rs3817198 variant is a common genetic change located within the LSP1 gene. Research has investigated its potential association with breast cancer risk, particularly in relation to environmental factors such as parity.
What each genotype means
Typical breast cancer risk
This genotype represents the common form of the LSP1 variant. Research indicates that this variant is studied as a potential modifier of breast cancer risk, particularly in individuals who carry BRCA1 or BRCA2 mutations. Please consult with a healthcare professional or genetic counselor to discuss how this information fits into your overall health profile.
This is a common genotype found across many global populations.
Potential breast cancer risk modifier
Carrying one copy of the T allele at this position in the LSP1 gene has been investigated for its association with breast cancer risk. Studies suggest this variant may act as a risk modifier in specific groups, such as BRCA1 and BRCA2 mutation carriers, though the overall impact is considered limited. Discuss your family history and genetic findings with a clinician to understand your personal risk factors.
This heterozygous genotype is frequently observed in diverse populations.
Potential breast cancer risk modifier
Carrying two copies of the T allele at this position in the LSP1 gene has been studied in the context of breast cancer susceptibility. While some research suggests this variant may influence risk, particularly for those with existing BRCA1 or BRCA2 mutations, the evidence remains limited and may vary by ancestry. This result should not be used for diagnostic purposes; please speak with a medical professional regarding your health screening needs.
This genotype is present at varying frequencies across different ancestral groups.
What is rs3817198?
The rs3817198 variant is a single nucleotide polymorphism (SNP) located in the LSP1 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found within the LSP1 gene, which provides instructions for making the Lymphocyte Specific Protein 1. This protein is primarily expressed in immune cells, including lymphocytes, neutrophils, and macrophages, where it functions as an intracellular F-actin-binding protein. Because this variant is common in the general population, it has been the subject of numerous genome-wide association studies (GWAS) aimed at identifying genetic markers that might contribute to complex disease risks. Scientists track these variants to understand how subtle differences in our genetic code might influence biological processes or susceptibility to health conditions over a lifetime.
The Role of the LSP1 Gene
The LSP1 gene encodes the Lymphocyte Specific Protein 1, a protein involved in the structural organization of the cytoskeleton within immune cells. By binding to F-actin, this protein helps regulate cell shape, motility, and other critical functions of white blood cells. While its primary role is within the immune system, researchers have long been interested in why variants within this gene appear in studies related to breast cancer. The hypothesis is that the protein's influence on cellular behavior or signaling pathways might indirectly affect tissue development or the body's response to environmental factors. It is important to note that having a variant in this gene does not mean the gene is 'broken' or non-functional; rather, it represents a natural variation in the human genome that may slightly alter how the protein is expressed or functions in different contexts.
Evidence and Research Findings
The evidence linking rs3817198 to breast cancer risk is considered limited and complex. Some studies have suggested that the risk associated with this variant may not be uniform across all individuals but instead depends on environmental factors. For example, research has explored potential interactions between this SNP and parity (the number of times a woman has given birth). One study indicated that the odds ratio for breast cancer risk associated with this variant varied significantly depending on the number of births a woman had experienced. Other studies have yielded mixed results, with some failing to find a statistically significant association after accounting for multiple testing. Because these findings are highly dependent on specific population groups and environmental contexts, the scientific community views this variant as a subject of ongoing investigation rather than a definitive diagnostic marker for breast cancer.
Population Frequency
The rs3817198 variant is considered a common polymorphism, meaning it is found frequently across diverse human populations. Because it is common, it is widely represented in large-scale genetic databases and GWAS datasets. However, the frequency of the specific alleles (T and C) can vary between different ancestral groups. Researchers often look at these frequency differences to determine if the variant's impact on health is consistent globally or if it is specific to certain populations. While the variant is common, its presence in an individual's genome is a standard feature of human genetic diversity and does not inherently indicate a health concern.
Interpreting Your Genetic Information
If you have information about your rs3817198 genotype, it is important to understand that this data is for educational purposes only. Genetic variants like rs3817198 are just one small piece of a much larger puzzle that includes your overall family history, lifestyle, and environmental exposures. This variant is not a diagnostic tool, and it cannot predict whether an individual will develop breast cancer. If you are concerned about your personal risk for breast cancer, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can evaluate your complete medical history and provide personalized guidance. Never make medical decisions based solely on genetic data from a report, and always discuss any health concerns with a qualified clinician who can interpret your results in the context of your total health profile.
How common is this variant?
The rs3817198 variant is a common polymorphism found across diverse global populations, with varying allele frequencies observed between different ancestral groups.
Frequently asked questions
Does having the rs3817198 variant mean I will get breast cancer?
No. This variant is associated with a very small change in relative risk in some studies, but it is not a diagnostic marker. Most people with this variant will never develop breast cancer, and many people who develop breast cancer do not carry this specific variant.
What is the LSP1 gene?
The LSP1 gene encodes a protein called Lymphocyte Specific Protein 1. This protein is primarily involved in the function and structure of immune cells.
Should I be worried about my rs3817198 result?
There is no reason to be worried. This is a common genetic variation found in many healthy people. Genetic risk factors are complex and should always be discussed with a doctor who understands your full medical history.
How can I use this information to lower my risk?
Genetic variants like this cannot be changed. Instead, focus on established health behaviors such as maintaining a healthy lifestyle, attending regular screenings, and discussing your family history with your healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3817198?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29